United States S 4199: Prescription Drug Pricing Reduction Act of 2020

Status: Introduced in Senate (as of 2020-07-02)

State: United States · Session: 116 · Bill: S 4199

Subjects: Accounting and auditing, Administrative law and regulatory procedures, Advisory bodies, Appropriations, Congressional oversight, Department of Health and Human Services, Drug safety, medical device, and laboratory regulation, Drug therapy, Emergency medical services and trauma care, Fraud offenses and financial crimes, Genetics, Government information and archives, Government studies and investigations, Health care costs and insurance, Health care coverage and access, Health care quality, Health information and medical records, Health programs administration and funding, Health technology, devices, supplies, Home and outpatient care, Hospital care, Indian social and development programs, Infectious and parasitic diseases, Inflation and prices, Intergovernmental relations, Manufacturing, Medicaid, Medical ethics, Medicare, Minority health, Poverty and welfare assistance, Prescription drugs, Public contracts and procurement, Public participation and lobbying, Retail and wholesale trades, Social work, volunteer service, charitable organizations, State and local government operations

Sponsors: CHARLES ERNEST GRASSLEY, Bill Cassidy, Cindy Hyde-Smith, Dan Sullivan, Joni Ernst, Lisa Murkowski, Martha McSally, Mike Braun, ROB PORTMAN, SUSAN MARGARET COLLINS, Steve Daines

View United States S 4199 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.